Raymond James Financial Services Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 4,417 shares of JAZZ stock, worth $548,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,417
Previous 5,391
18.07%
Holding current value
$548,370
Previous $575,000
14.43%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$763 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$749 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$314 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$275 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$253 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.78B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...